Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029

Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029

No trades
See on Supercharts

Key terms


Outstanding amount
‪316.25 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
4.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−4.91%
Maturity date
May 1, 2029
Term to maturity
4 years

About Mirum Pharmaceuticals, Inc. 4.0% 01-MAY-2029


Sector
Health Technology
Issue date
Apr 30, 2024
FIGI
BBG01G6VXFH0
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.